Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.3K Sell
260
-27
-9% -$9.63K 0.04% 212
2025
Q4
$93.8K Buy
287
+1
+0.3% +$317 0.04% 227
2025
Q3
$80.6K Buy
+286
New +$82.9K 0.04% 242

Other funds holding AMGN

Westfuller Advisors's AMGN Position: Q1 2026 in Review

Westfuller Advisors reduced its Amgen (AMGN) stake by 9.4% in Q1 2026, selling an estimated $9.63K and leaving 260 shares worth $91.3K. The position accounts for 0.04% of the portfolio, ranked #212.

Westfuller Advisors first reported a position in AMGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $93.8K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Westfuller Advisors held 260 shares of Amgen worth $91.3K as of Q1 2026.
  • Westfuller Advisors sold 27 Amgen shares in Q1 2026, an estimated $9.63K.
  • Amgen made up 0.04% of Westfuller Advisors's portfolio in Q1 2026, its #212 holding.
  • Westfuller Advisors first reported a position in Amgen in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's Amgen position peaked at $93.8K in Q4 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.